chr1-109713540-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_000851.4(GSTM5):āc.234C>Gā(p.Arg78Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00597 in 1,613,106 control chromosomes in the GnomAD database, including 81 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0059 ( 6 hom., cov: 33)
Exomes š: 0.0060 ( 75 hom. )
Consequence
GSTM5
NM_000851.4 synonymous
NM_000851.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.29
Genes affected
GSTM5 (HGNC:4637): (glutathione S-transferase mu 5) Cytosolic and membrane-bound forms of glutathione S-transferase are encoded by two distinct supergene families. At present, eight distinct classes of the soluble cytoplasmic mammalian glutathione S-transferases have been identified: alpha, kappa, mu, omega, pi, sigma, theta and zeta. This gene encodes a glutathione S-transferase that belongs to the mu class. The mu class of enzymes functions in the detoxification of electrophilic compounds, including carcinogens, therapeutic drugs, environmental toxins and products of oxidative stress, by conjugation with glutathione. The genes encoding the mu class of enzymes are organized in a gene cluster on chromosome 1p13.3 and are known to be highly polymorphic. These genetic variations can change an individual's susceptibility to carcinogens and toxins as well as affect the toxicity and efficacy of certain drugs. Diversification of these genes has occurred in regions encoding substrate-binding domains, as well as in tissue expression patterns, to accommodate an increasing number of foreign compounds. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 1-109713540-C-G is Benign according to our data. Variant chr1-109713540-C-G is described in ClinVar as [Benign]. Clinvar id is 784446.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00585 (885/151252) while in subpopulation SAS AF= 0.019 (91/4796). AF 95% confidence interval is 0.0158. There are 6 homozygotes in gnomad4. There are 441 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 6 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GSTM5 | NM_000851.4 | c.234C>G | p.Arg78Arg | synonymous_variant | 4/8 | ENST00000256593.8 | NP_000842.2 | |
GSTM5 | XM_005270784.5 | c.234C>G | p.Arg78Arg | synonymous_variant | 5/9 | XP_005270841.1 | ||
GSTM5 | XM_005270785.5 | c.-53-121C>G | intron_variant | XP_005270842.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GSTM5 | ENST00000256593.8 | c.234C>G | p.Arg78Arg | synonymous_variant | 4/8 | 1 | NM_000851.4 | ENSP00000256593.3 |
Frequencies
GnomAD3 genomes AF: 0.00584 AC: 882AN: 151134Hom.: 5 Cov.: 33
GnomAD3 genomes
AF:
AC:
882
AN:
151134
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00755 AC: 1900AN: 251492Hom.: 21 AF XY: 0.00845 AC XY: 1149AN XY: 135922
GnomAD3 exomes
AF:
AC:
1900
AN:
251492
Hom.:
AF XY:
AC XY:
1149
AN XY:
135922
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00598 AC: 8742AN: 1461854Hom.: 75 Cov.: 34 AF XY: 0.00668 AC XY: 4861AN XY: 727224
GnomAD4 exome
AF:
AC:
8742
AN:
1461854
Hom.:
Cov.:
34
AF XY:
AC XY:
4861
AN XY:
727224
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00585 AC: 885AN: 151252Hom.: 6 Cov.: 33 AF XY: 0.00597 AC XY: 441AN XY: 73922
GnomAD4 genome
AF:
AC:
885
AN:
151252
Hom.:
Cov.:
33
AF XY:
AC XY:
441
AN XY:
73922
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
31
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 26, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: -1
Find out detailed SpliceAI scores and Pangolin per-transcript scores at